Clinical Trial Update: Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether tamoxifen reduces unscheduled bleeding in new users of the levonorgestrel-releasing intrauterine system (LNG-IUS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Metrorrhagia

Drugs mentioned

• Levonorg Estrogen-releasing Intrauterine System (LNG-IUS) (levonorgestrel-releasing intrauterine system)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Menorrhagia, Metrorrhagia | Phase 4 | Status: COMPLETED | Results posted: 2019-05-21